SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Chou S. (2008) Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir. Rev Med Virol 18: 23346.
  • 2
    Chou S. (2011) Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapy. J Clin Virol 50: 28791.
  • 3
    Gilbert C., Bestman-Smith J., Boivin G. (2002) Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms. Drug Resist Updat 5: 88114.
  • 4
    Hakki M., Chou S. (2011) The biology of cytomegalovirus drug resistance. Curr Opin Infect Dis 24: 60511.
  • 5
    Lurain N.S., Chou S. (2010) Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev 23: 689712.
  • 6
    Kuramoto T., Daikoku T., Yoshida Y., Takemoto M., Oshima K., Eizuru Y., Kanda Y., Miyawaki T., Shiraki K., Novel anticytomegalovirus activity of immunosuppressant mizoribine and its synergism with ganciclovir. J Pharmacol Exp Ther 333: 81621.
  • 7
    Oshima K., Kanda Y., Kako S., Asano-Mori Y., Watanabe T., Motokura T., Chiba S., Shiraki K., Kurokawa M. (2008) Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes. J Med Virol 80: 176975.
  • 8
    Shiraki K., Ishibashi M., Okuno T., Kokado Y., Takahara S., Yamanishi K., Sonoda T., Takahashi M. (1990) Effects of cyclosporine, azathioprine, mizoribine, and prednisolone on replication of human cytomegalovirus. Transplant Proc 22: 16825.
  • 9
    Yukawa T.A., Kurokawa M., Sato H., Yoshida Y., Kageyama S., Hasegawa T., Namba T., Imakita M., Hozumi T., Shiraki K. (1996) Prophylactic treatment of cytomegalovirus infection with traditional herbs. Antiviral Res 32: 6370.
  • 10
    Boivin G., Goyette N., Farhan M., Ives J., Elston R. (2012) Incidence of cytomegalovirus UL97 and UL54 amino acid substitutions detected after 100 or 200 days of valganciclovir prophylaxis. J Clin Virol 53: 20813.
  • 11
    Couzi L., Helou S., Bachelet T., Moreau K., Martin S., Morel D., Lafon M.E., Boyer B., Alain S., Garrigue I., Merville P. (2012) High incidence of anticytomegalovirus drug resistance among D + R-kidney transplant recipients receiving preemptive therapy. Am J Transplant 12: 2029.
  • 12
    Eckle T., Jahn G., Hamprecht K. (2004) The influence of mixed HCMV UL97 wild type and mutant strains on ganciclovir susceptibility in a cell associated plaque reduction assay. J Clin Virol 30: 506.
  • 13
    Erice A. (1999) Resistance of human cytomegalovirus to antiviral drugs. Clin Microbiol Rev 12: 28697.
  • 14
    Madi N., Al-Nakib W., Pacsa A. (2011) Does cytomegalovirus develop resistance following antiviral prophylaxis and treatment in renal transplant patients in Kuwait? Adv Virol 2011: 260561. doi: 10.1155/2011/260561. Epub2011 Mar 24
  • 15
    Myhre H.A., Haug Dorenberg D. Kristiansen K.I., Rollag H., Leivestad T., Asberg A., Hartmann A., Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients. Transplantation 92: 21723.
  • 16
    Lurain N.S., Weinberg A., Crumpacker C.S., Chou S. (2001) Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing. Antimicrob Agents Chemother 45: 277580.
  • 17
    Van Der Beek M.T., Marijt E.W., Vossen A.C., Van Der Blij-De Brouwer C.S., Wolterbeek R., Halkes C.J., Claas E.C., Kroes A.C. (2012) Failure of pre-emptive treatment of cytomegalovirus infections and antiviral resistance in stem cell transplant recipients. Antivir Ther 17: 4551.
  • 18
    Castor J., Cook L., Corey L., Jerome K.R. (2007) Rapid detection directly from patient serum samples of human cytomegalovirus UL97 mutations conferring ganciclovir resistance. J Clin Microbiol 45: 26813.
  • 19
    Gohring K., Mikeler E., Jahn G., Hamprecht K. (2006) Rapid simultaneous detection by real-time PCR of cytomegalovirus UL97 mutations in codons 460 and 520 conferring ganciclovir resistance. J Clin Microbiol 44: 45414.
  • 20
    Gohring K., Mikeler E., Jahn G., Rohde F., Hamprecht K. (2008) Rapid semiquantitative real-time PCR for the detection of human cytomegalovirus UL97 mutations conferring ganciclovir resistance. Antivir Ther 13: 4616.
  • 21
    Jabs D.A., Martin B.K., Ricks M.O., Forman M.S. (2006) Detection of ganciclovir resistance in patients with AIDS and cytomegalovirus retinitis: correlation of genotypic methods with viral phenotype and clinical outcome. J Infect Dis 193: 172837.
  • 22
    Lee G.C., Lee D.G., Choi S.M., Yoo J.H., Park S.H., Choi J.H., Min W.S., Cho O.H., Lee C.H., Shin W.S. (2005) Use of time-saving flow cytometry for rapid determination of resistance of human cytomegalovirus to ganciclovir. J Clin Microbiol 43: 50038.
  • 23
    Yeo A.C., Chan K.P., Kumarasinghe G., Yap H.K. (2005) Rapid detection of codon 460 mutations in the UL97 gene of ganciclovir-resistant cytomegalovirus clinical isolates by real-time PCR using molecular beacons. Mol Cell Probes 19: 38993.
  • 24
    Zhou L., Harder T.C., Ullmann U., Rautenberg P. (1999) Rapid detection by reverse hybridization of mutations in the UL97 gene of human cytomegalovirus conferring resistance to ganciclovir. J Clin Virol 13: 539.
  • 25
    Zurcher S., Mooser C., Luthi A.U., Muhlemann K., Barbani M.T., Mohacsi P., Garzoni C., Gorgievski-Hrisoho M., Schaller A., Flatz L. (2012) Sensitive and rapid detection of ganciclovir resistance by PCR based MALDI-TOF analysis. J Clin Virol 54: 35963.
  • 26
    Chou S., Lurain N.S., Weinberg A., Cai G.Y., Sharma P.L., Crumpacker C.S., Adult AIDS Clinical Trials Group CMV Laboratories. (1999) Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Antimicrob Agents Chemother 43: 15002.